Smads as intracellular mediators of airway inflammation

Experimental Lung Research

Volumn 30, Issue 3, 2004, Pages 223-250

  Groneberg, David A ^a,d   Witt, Heiko ^a   Adcock, Ian M ^b   Hansen, Gesine ^c   Springer, Jochen ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Airway; Asthma; COPD; Inflammation; Intracellular; Lung; Marker; Mediator; Smad; TGI; Transforming growth factor

Indexed keywords

ACTIVIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SMAD8 PROTEIN; SMAD9 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UNCLASSIFIED DRUG;

ALLERGIC ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; DOWN REGULATION; HUMAN; MEDIATOR RELEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PNEUMONIA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANS-ACTIVATORS;

EID: 1642570312     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490276320     Document Type: Review

References (197)

1. Barnes PJ, Woolcock AJ: Difficult asthma. Eur Respir J. 1998;12:1209-1218.
2. Chung KF, Barnes PJ: Cytokines in asthma. Thorax. 1999;54:825-857.
3. Barnes PJ: Th2 cytokines and asthma: an introduction. Respir Res. 2001;2:64-65.
4. Nadel JA, Busse WW: Asthma. Am J Respir Crit Care Med. 1998;157:S130-S138.
5. O'Byrne PM, Inman MD: Airway hyperresponsiveness. Chest. 2003;123:411S-416S.
6. Sterk PJ: Airway hyperresponsiveness: using bronchial challenge tests in research and management of asthma. J Aerosol Med. 2002;15:123-129.
7. Groneberg DA, Eynott PR, Lim S, Oates T, Wu R, Carlstedt I, Roberts P, McCann B, Nicholson AG, Harrison BD, Chung KF: Expression of respiratory mucins in fatal status asthmaticus and mild asthma. Histopathology. 2002;40:367-373.
8. Groneberg DA, Eynott PR, Oates T, Lim S, Wu R, Carlstedt I, Nicholson AG, Chung KF: Expression of MUC5AC and MUC5B mucins in normal and cystic fibrosis lung. Respir Med. 2002;96:81-86.
9. Groneberg DA, Peiser C, Dinh QT, Matthias J, Eynott PR, Heppt W, Carlstedt I, Witt C, Fischer A, Chung KF: Distribution of respiratory mucin proteins in human nasal mucosa. Laryngoscope. 2003;113:520-524.
10. Vignola AM, La Grutta S, Chiappara G, Benkeder A, Bellia V, Bonsignore G: Cellular network in airways inflammation and remodelling. Paediatr Respir Rev. 2002;3:41-46.
11. Beckett PA, Howarth PH: Pharmacotherapy and airway remodelling in asthma? Thorax. 2003;58:163-174.
12. Barnes PJ, Chung KF, Page CP: Inflammatory mediators of asthma: an update. Pharmacol Rev. 1998;50:515-596.
13. Groneberg DA, Fischer A: Endogenous opioids as mediators of asthma. Pulm Pharmacol Ther. 2001;14:383-389.
14. Hansen G, McIntire JJ, Yeung VP, Berry G, Thorbecke GJ, Chen L, DeKruyff RH, Umetsu DT: CD4(+) T helper cells engineered to produce latent TGF-beta1 reverse allergen-induced airway hyperreactivity and inflammation. J Clin Invest. 2000;105:61-70.
15. Haneda K, Sano K, Tamura G, Shirota H, Ohkawara Y, Sato T, Habu S, Shirato K: Transforming growth factor-beta secreted from CD4(+) T cells ameliorates antigen-induced eosinophilic inflammation. A novel high-dose tolerance in the trachea. Am J Respir Cell Mol Biol. 1999;21:268-274.
16. Haneda K, Sano K, Tamura G, Sato T, Habu S, Shirato K: TGF-beta induced by oral tolerance ameliorates experimental tracheal eosinophilia. J Immunol. 1997;159:4484-4490.
17. Nakao A: Is TGF-beta1 the key to suppression of human asthma? Trends Immunol. 2001;22:115-118.
18. Nakao A, Miike S, Hatano M, Okumura K, Tokuhisa T, Ra C, Iwamoto I: Blockade of transforming growth factor beta/Smad signaling in T cells by overexpression of Smad7 enhances antigen-induced airway inflammation and airway reactivity. J Exp Med. 2000;192:151-158.
19. Nakao A, Sagara H, Setoguchi Y, Okada T, Okumura K, Ogawa H, Fukuda T: Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. J Allergy Clin Immunol. 2002;110:873-878.
20. Gorelik L, Flavell RA: Transforming growth factor-beta in T-cell biology. Nat Rev Immunol. 2002;2:46-53.
21. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew S, Sporn MB, Fauci AS: Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J Immunol. 1986;137:3855-3860.
22. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163:1037-1050.
23. Wahl SM, Hunt DA, Wong HL, Dougherty S, McCartney-Francis N, Wahl LM, Ellingsworth L, Schmidt JA, Hall G, Roberts AB, et al.: Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation. J Immunol. 1988;140:3026-3032.
24. Espevik T, Figari IS, Shalaby MR, Lackides GA, Lewis GD, Shepard HM, Palladino MA Jr: Inhibition of cytokine production by cyclosporin A and transforming growth factor beta. J Exp Med. 1987;166: 571-576.
25. Brandes ME, Allen JB, Ogawa Y, Wahl SM: Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals. J Clin Invest 1991;87:1108-1113.
26. Kuruvilla AP, Shah R, Hochwald GM, Liggitt HD, Palladino MA, Thorbecke GJ: Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci U S A. 1991;88:2918-2921.
27. Kulkarni AB, Huh CG, Becker D, Geiser A, Lyght M, Flanders KC, Roberts AB, Sporn MB, Ward JM, Karlsson S: Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci USA. 1993;90:770-774.
28. Sengler C, Lau S, Wahn U, Nickel R: Interactions between genes and environmental factors in asthma and atopy: new developments. Respir Res. 2002;3:7.
29. Olgart Hoglund C, Frossard N: Nerve growth factor and asthma. Pulm Pharmacol Ther. 2002;15:51-60.
30. Fischer A, Folkerts G, Geppetti P, Groneberg DA: Mediators of asthma: nitric oxide. Pulm Pharmacol Ther. 2002;15:73-81.
31. Henricks PA, Nijkamp FP: Reactive oxygen species as mediators in asthma. Pulm Pharmacol Ther. 2001;14:409-420.
32. Heppt W, Peiser C, Cryer A, Dinh QT, Zweng M, Witt C, Fischer A, Groneberg DA: Innervation of human nasal mucosa in environmentally triggered hyperreflectoric rhinitis. J Occup Environ Med. 2002;44:924-929.
33. Cocks TM, Moffatt JD: Protease-activated receptor-2 (PAR2) in the airways. Pulm Pharmacol Ther. 2001;14:183-191.
34. Piek E, Heldin CH, Ten Dijke P: Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J. 1999;13:2105-2124.
35. Bello-DeOcampo D, Tindall DJ: TGF-beta1/Smad signaling in prostate cancer. Curr Drug Targets. 2003;4:197-207.
36. Miyazono K: Regulation of transforming growth factor-beta signaling and vascular diseases. Cornea. 2002;21:S48-S53.
37. Ihn H: The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma. Arch Immunol Ther Exp (Warsz). 2002;50:325-331.
38. Chang H, Brown CW, Matzuk MM: Genetic analysis of the mammalian transforming growth factor-beta superfamily. Endocr Rev. 2002;23:787-823.
39. van Grunsven LA, Huylebroeck D, Verschueren K: Complex Smad-dependent transcriptional responses in vertebrate development and human disease. Crit Rev Eukaryot Gene Expr. 2002;12:101-118.
40. Khalil N: TGF-[beta]: from latent to active. Microbes Infect. 1999;1:1255-1263.
41. Vodovotz Y, Chesler L, Chong H, Kim S-J, Simpson JT, Degraff W, Cox GW, Roberts AB, Wink DA, Barcellos-Hoff MH: Regulation of transforming growth factor [beta] 1 by nitric oxide. Cancer Res. 1999;59:2142-2149.
42. Yehualaeshet T, O'Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, Khalil N: Activation of rat alveolar macrophage-derived latent transforming growth factor [beta]-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol. 1999;155:841-851.
43. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-[beta] secreted by endothelial cells by a novel mechanism. J Cell Biol. 1993;122:923-932.
44. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE: Thrombospondin binds and activates the small and large forms of latent transforming growth factor-[β] in a chemically defined system. J Biol Chem. 1994;269:26775-26782.
45. Crawford SE, Stellmach V, Murphy-Ullrich JE, Ribeiro SMF, Lawler J, Hynes RO, Bolvin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-[β]1 in vivo. Cell. 1998;93:1159-1170.
46. Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB: Recombinant latent transforming growth factor [β]1 has a longer plasma half-life in rats than active transforming growth factor [beta]1, and a different tissue distribution. J Clin Invest. 1990;86:1976-1984.
47. Munger JS, Huang X, Kawakatsu H, Griffiths MJD, Dalton SL, WuJ, PittetJ-F, Kaminski N, Garat C, Matthay MA, Rifkin DB, Sheppard D: The integrin [α]v[β]6 binds and activates latent TGF[β]1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319-328.
48. Nunes I, Shapiro RL, Rifkin DB: Characterization of latent TGF-[β] activation by murine peritoneal macrophages. J Immunol. 1995;155:1450-1459.
49. Mehra A, Wrana JL: TGF-beta and the Smad signal transduction pathway. Biochem Cell Biol. 2002;80:605-622.
50. Kingsley DM: The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 1994;8:133-146.
51. Attisano L, Wrana JL, Lopez-Casillas F, Massague J: TGF-beta receptors and actions. Biochim Biophys Acta. 1994;1222:71-80.
52. Groneberg DA, Nickolaus M, Springer J, Doring F, Daniel H, Fischer A: Localization of the peptide transporter PEPT2 in the lung: implications for pulmonary oligopeptide uptake. Am J Pathol. 2001;158:707-714.
53. Groneberg DA, Eynott PR, Doring F, Thai Dinh Q, Oates T, Barnes PJ, Chung KF, Daniel H, Fischer A: Distribution and function of the peptide transporter PEPT2 in normal and cystic fibrosis human lung. Thorax. 2002;57:55-60.
54. Groneberg DA, Doring F, Eynott PR, Fischer A, Daniel H: Intestinal peptide transport: ex vivo uptake studies and localization of peptide carrier PEPT1. Am J Physiol Gastrointest Liver Physiol. 2001;281:G697-G704.
55. Groneberg DA, Doring F, Nickolaus M, Daniel H, Fischer A: Expression of PEPT2 peptide transporter mRNA and protein in glial cells of rat dorsal root ganglia. Neurosci Lett. 2001;304:181-184.
56. Dinh QT, Peiser C, Fischer A, Groneberg DA: Re-uptake mechanisms of peptide fragments after DPP IV-mediated proteolysis in the peripheral nervous system. Adv Exp Med Biol. 2003;524:73-76.
57. Groneberg DA, Doring F, Nickolaus M, Daniel H, Fischer A: Renal assimilation of short chain peptides: visualization of tubular peptide uptake. Pharm Res. 2002;19:1209-1214.
58. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M, Wang XF, Massague J: TGF beta signals through a heteromeric protein kinase receptor complex. Cell. 1992;71:1003-1014.
59. Massague J: TGF-[β] signal transduction. Annu Rev Biochem. 1998;67:753-791.
60. Cheifetz S, Andres J, Massague J: The transforming growth factor-beta receptor type in is a membrane proteoglycan. Domain structure of the receptor. J Biol Chem. 1988;263:16984-16991.
61. Lopez-Casillas F, WranaJL, Massague J: Betaglycan presents ligand to the TGF beta signaling receptor. Cell. 1993;73:1435-1444.
62. Gougos A, Letarte M: Primary structure of endoglin, an RGD-containing glycoprotein of human endothelial cells. J Biol Chem. 1990;265:8361-8364.
63. Cheifetz S, Bellon T, Cales C, Vera S, Bernabeu C, Massague J, Letarte M: Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem. 1992;267:19027-19030.
64. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature. 1990;346:281-284.
65. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA: Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med. 1996;2:418-423.
66. Gold LI: The role for transforming growth factor-beta (TGF-beta) in human cancer. Crit Rev Oncogene. 1999;10:303-360.
67. Heldin CH, Miyazono K, ten Dijke P: TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature. 1997;390:465-471.
68. Liu F, Pouponnot C, Massague J: Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta -inducible transcriptional complexes. Genes Dev. 1997;11:3157-3167.
69. Shi Y, Hata A, Lo RS, Massague J, Pavletich NP: A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature. 1997;388:87-93.
70. Shi Y, Wang YF, Jayaraman L, Yang H, Massague J, Pavletich NP: Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell. 1998;94:585-594.
71. Derynck R, Zhang Y Feng XH: Smads: transcriptional activators of TGF-beta responses. Cell. 1998;95:737-740.
72. Hata A, Lo RS, Wotton D, Lagna G, Massague J: Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature. 1997;388:82-87.
73. Wu R, Zhang Y Feng X, Derynck R: Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4. Mol. Cell. Biol. 1997;17:2521-2528.
74. Lagna G, Hata A, Hemmati-Brivanlou A, Massague J: Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature. 1996;383:832-836.
75. Masuyama N, Hanafusa H, Kusakabe M, Shibuya H, Nishida E: Identification of Two Smad4 Proteins in Xenopus. Their common and distinct properties. J Biol Chem. 1999;274:12163-12170.
76. Liberati NT, Datto MB, Frederick JP, Shen X, Wong C, Rougier-Chapman EM, Wang X-F: Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci U S A. 1999;96:4844-4849.
77. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier J-M: Direct binding of Smad3 and Smad4 to critical TGFbeta -inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 1998;17:3091-3100.
78. Yingling J, Datto M, Wong C, Frederick J, Liberati N, Wang X: Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol. 1997;17:7019-7028.
79. Roberts AB: Molecular and cell biology of TGF-beta. Miner Electrolyte Metab. 1998;24:111-119.
80. Eppert K, Scherer SW, Ozcelik H, Pirone R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L: MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 1996;86:543-552.
81. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science. 1996;271:350-353.
82. Zhang Y, Musci T, Derynck R: The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function. Curr Biol. 1997;7:270-276.
83. Yanagisawa K, Uchida K, Nagatake M, Masuda A, Sugiyama M, Saito T, Yamaki K, Takahashi T, Osada H: Heterogeneities in the biological and biochemical functions of Smad2 and Smad4 mutants naturally occurring in human lung cancers. Oncogene. 2000;19:2305-2311.
84. Hua X, Liu X, Ansari DO, Lodish HF: Synergistic cooperation of TFE3 and Smad proteins in TGF-[β]-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev. 1998;12: 3084-3095.
85. Grinberg AV, Kerppola T: Both Max and TFE3 cooperate with Smad proteins to bind the plasminogen activator inhibitor-1 promoter, but they have opposite effects on transcriptional activity. J Biol Chem. 2003;278:11227-11236.
86. Nagatake M, Takagi Y, Osada H, Uchida K, Mitsudomi T, Saji S, Shimokata K, Takahashi T: Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res. 1996;56: 2718-2720.
87. Schutte M, Hruban R, Hedrick L, Cho K, Nadasdy G, Weinstein C, Bova G, Isaacs W, Cairns P, Nawroz H, Sidransky D, Casero R, Jr, Meltzer P, Hahn S, Kern S: DPC4 gene in various tumor types. Cancer Res. 1996;56:2527-2530.
88. Kim S, Fan Y, Papadimitrakopoulou V, Clayman G, Hittelman W, Hong W, Lotan R, Mao L: DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res. 1996;56:2519-2521.
89. Reiss M, Santoro V, de Jonge R, Vellucci V: Transfer of chromosome 18 into human head and neck squamous carcinoma cells: evidence for tumor suppression by Smad4/DPC4. Cell Growth Differ. 1997;8:407-415.
90. Peiser C, Springer J, Groneberg DA, McGregor GP, Fischer A, Lang RE: Leptin receptor expression in nodose ganglion cells projecting to the rat gastric fundus. Neurosci Lett. 2002;320:41-44.
91. Hannon GJ: RNA interference. Nature. 2002;418:244-251.
92. Hanze J, Groneberg DA, Rose F, Hanisch A, Dotsch J, Peiser C, Seeger W, Rascher W, Fischer A, Grimminger F: Genomic organization and regulation of a human 7-helix transmembrane receptor which is expressed in pulmonary epithelial cells and induced in hypoxia. Biochem Biophys Res Commun. 2002;291:1160-1165.
93. Groneberg DA, Heppt W, Cryer A, Wussow A, Peiser C, Zweng M, Dinh QT, Witt C, Fischer A: Toxic rhinitis-induced changes of human nasal mucosa innervation. Toxicol Pathol. 2003;31:326-331.
94. Groneberg DA, Peiser C, Fischer A: Distribution of salivary aquaporin-5 in Sjogren's syndrome. Lancet. 2002;359:1778-1779.
95. Fischer TC, Dinh QT, Peiser C, Loser C, Fischer A, Groneberg DA: Simultaneous detection of receptor mRNA and ligand protein in human skin tissues. J Cutan Pathol. 2002;29:65-71.
96. Jacob P, Rossmann H, Lamprecht G, Kretz A, Neff C, Lin-Wu E, Gregor M, Groneberg DA, Kere J, Seidler U: Down-regulated in adenoma mediates apical Cl - /HCO3 - exchange in rabbit, rat, and human duodenum. Gastroenterology. 2002;122:709-724.
97. Fischer TC, Hartmann P, Loser C, Springer J, Peiser C, Dinh QT, Fischer A, Groneberg DA: Abundant expression of vasoactive intestinal polypeptide receptor VPAC2 mRNA in human skin. J Invest Dermatol. 2001;117:754-756.
98. Groneberg DA, Hartmann P, Dinh QT, Fischer A: Expression and distribution of vasoactive intestinal polypeptide receptor VPAC (2) mRNA in human airways. Lab Invest 2001;81:749-755.
99. Lim S, Groneberg D, Fischer A, Oates T, Caramori G, Mattos W, Adcock I, Barnes PJ, Chung KF: Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways: effect of inhaled corticosteroids. Am J Respir Crit Care Med. 2000;162:1912-1918.
100. Groneberg DA, Doring F, Theis S, Nickolaus M, Fischer A, Daniel H: Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein. Am J Physiol Endocrinol Metab. 2002;282:E1172-E1179.
101. Yakymovych I, Ten Dijke P, Heldin CH, Souchelnytskyi S: Regulation of Smad signaling by protein kinase C. FASEB J. 2001;15:553-555.
102. Kucich U, Rosenbloom JC, Herrick DJ, Abrams WR, Hamilton AD, Sebti SM, Rosenbloom J: Signaling events required for transforming growth factor-beta stimulation of connective tissue growth factor expression by cultured human lung fibroblasts. Arch Biochem Biophys. 2001;395:103-112.
103. Kucich U, Rosenbloom JC, Abrams WR, Rosenbloom J: Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38. Am J Respir Cell Mol Biol. 2002;26:183-188.
104. Runyan CE, Schnaper HW, Poncelet AC: Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells. Am J Physiol Renal Physiol. 2003;285:F413-F422.
105. DiChiara MK, KielyJM, Gimbrone M.A. J, Lee M-E, Perrella MA, Topper JN: Inhibition of E-selectin gene expression by transforming growth factor [beta] in endothelial cells involves coactivator integration of Smad and nuclear factor [κ]B-mediated signals. J Exp Med. 2000;192:695-704.
106. Cano E, Mahadevan LC: Parallel signal processing among mammalian MAPKs. Trends Biochem Sci. 1995;20:117-122.
107. Zhang Y, Feng X-H, Derynck R: Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-[β]-induced transcription. Nature. 1998;394:909-913.
108. Groneberg DA, Wiegand S, Dinh QT, Peiser C, Springer J, Fischer A: Expression of immediate early genes in sensory ganglia. Neurochem Res. 2001;26:1113-1117.
109. Groneberg DA, Peiser C, Dinh QT, Springer J, Fischer A: Abundant expression of c-Jun in guinea pig sympathetic ganglia under basal conditions and allergen challenge. Lung. 2002;180:221-228.
110. Kauffmann-Zeh A, Rodriguez-Viciana P, Ulrich E, Gilbert C, Coffer P, Downward J, Evan G: Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 1997;385: 544-548.
111. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis. Science. 1995;270:1326-1331.
112. Yue J, Frey RS, Mulder KM: Cross-talk between the Smad1 and Ras/MEK signaling pathways for TGFbeta. Oncogene. 1999;18:2033-2037.
113. Sano Y, Harada J, Tashiro S, Gotoh-Mandeville R, Maekawa T, Ishii S: ATF-2 is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. J Biol Chem. 1999;274:8949-8957.
114. Kretzschmar M, Doody J, Timokhina I, Massague J: A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 1999;13:804-816.
115. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N, Taniguchi T, Nishida E, Matsumoto K: Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science. 1995;270:2008-2011.
116. Shibuya H, Yamaguchi K, Shirakabe K, Tonegawa A, Gotoh Y, Ueno N, Irie K, Nishida E, Matsumoto K: TAB1: An activator of the TAK1 MAPKKK in TGF-beta signal transduction. Science. 1996;272:1179-1182.
117. Hartsough MT, Mulder KM: Transforming growth factor beta activation of p44[mapR] in proliferating cultures of epithelial cells. J Biol Chem. 1995;270:7117-7124.
118. de Caestecker MP, Parks WT, Frank CJ, Castagnino P, Bottaro DP, Roberts AB, Lechleider RJ: Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev. 1998;12:1587-1592.
119. Zhang Y, Derynck R: Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol. 1999;9:274-279.
120. Brown JD, DiChiara MR, Anderson KR, Gimbrone MA Jr, Topper JN: MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem. 1999;274:8797-8805.
121. Hamaguchi A, Kim S, Izumi Y, Zhan Y, Yamanaka S, Iwao H: Contribution of extracellular signalregulated kinase to angiotensin II-induced transforming growth factor-[β]1 Expression in vascular smooth muscle cells. Hypertension. 1999;34:126-131.
122. Wang W, Zhou G, Hu MC-T, Yao Z, Tan T-H: Activation of the hematopoietic progenitor kinase-1 (HPK1)-dependent, stress-activated c-Jun N-terminal kinase (JNK) pathway by transforming growth factor beta (TGF-beta)-activated kinase (TAK1), a kinase mediator of TGF beta signal transduction. J Biol Chem. 1997;272:22771-22775.
123. Terada Y, Inoshita S, Nakashima O, Kuwahara M, Sasaki S, Marumo F: Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int. 1999;56:1258-1261.
124. Moriguchi T, Kuroyanagi N, Yamaguchi K, Gotoh Y, Irie K, Kano T, Shirakabe K, Muro Y, Shibuya H, Matsumoto K, Nishida E, Hagiwara M: A novel kinase cascade mediated by mitogen-activated protein kinase kinase 6 and MKK3. J Biol Chem. 1996;271:13675-13679.
125. Terada Y, Nakashima O, Inoshita S, Kuwahara M, Sasaki S, Marumo F: TGF-beta-activating kinase-1 inhibits cell cycle and expression of cyclin D1 and A in LLC-PK1 cells. Kidney Int. 1999;56:1378-1390.
126. Kimura N, Matsuo R, Shibuya H, Nakashima K, Taga T: BMP2-induced apoptosis is mediated by activation of the TAK1-p38 kinase pathway that is negatively regulated by Smad6. J Biol Chem. 2000;275:17647-17652.
127. Mazars A, Lallemand F, Prunier C, Marais J, Ferrand N, Pessah M, Cherqui G, Atfi A: Evidence for a role of the JNK cascade in Smad7-mediated apoptosis. J Biol Chem. 2001;276:36797-36803.
128. Pessah M, Marais J, Prunier C, Ferrand N, Lallemand F, Mauviel A, Atfi A: c-Jun associates with the oncoprotein Ski and suppresses Smad2 transcriptional activity. J Biol Chem. 2002;277:29094-29100.
129. Zhou S, Zawel L, Lengauer C, Kinzler KW, Vogelstein B: Characterization of human FAST-1, a TGF beta and activin signal transducer. Mol Cell. 1998;2:121-127.
130. Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S: Convergence of transforming growth factor-[β] and vitamin D signaling pathways on SMAD transcriptional coactivators. Science. 1999;283:1317-1321.
131. Li C, Zhu N-L, Tan RC, Ballard PL, Derynck R, Minoo P: Transforming growth factor-[β] inhibits pulmonary surfactant protein B gene transcription through SMAD3 interactions with NKX2.1 and HNF-3 transcription factors. J Biol Chem. 2002;277:38399-38408.
132. Moustakas A, Kardassis D: Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. Proc Natl Acad Sci U S A. 1998;95:6733-6738.
133. Marshall RP, Gohlke P, Chambers RC, Howell DC, Bottoms S, Unger T, McAnulty RJ, Laurent GJ: Angiotensin II and the fibroproliferative response to acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2003;286:L156-164.
134. Reddi K, Phagoo SB, Anderson KD, Warburton D: Burkholderia cepacia-induced IL-8 gene expression in an alveolar epithelial cell line: signaling through CD14 and mitogen-activated protein kinase. Pediatr Res. 2003;54:297-305.
135. Utsugi M, Dobashi K, Ishizuka T, Masubuchi K, Shimizu Y, Nakazawa T, Mori M: C-Jun NH2-terminal kinase mediates expression of connective tissue growth factor induced by transforming growth factor-[β]1 in human lung fibroblasts. Am J Respir Cell Mol Biol. 2003;28:754-761.
136. Li LF, Ouyang B, Choukroun G, Matyal R, Mascarenhas M, Jafari B, Bonventre JV, Force T, Quinn DA: Stretch-induced IL-8 depends on c-JUN N-terminal and nuclear factor-{κ}B-inducing kinases. Am J Physiol Lung Cell Mol Physiol. 2003;285:464-475.
137. Ingram JL, Rice AB, Santos J, Van Houten B, Bonner JC: Vanadium-induced HB-EGF expression in human lung fibroblasts is oxidant dependent and requires MAP kinases. Am J Physiol Lung Cell Mol Physiol. 2003;284:L774-L782.
138. Cummins AB, Palmer C, Mossman BT, Taatjes DJ: Persistent localization of activated extracellular signal-regulated kinases (ERK1/2) is epithelial cell-specific in an inhalation model of asbestosis. Am J Pathol. 2003;162:713-720.
139. Neugarten J, Medve I, Lei J, Silbiger SR: Estradiol suppresses mesangial cell type I collagen synthesis via activation of the MAP kinase cascade. Am J Physiol Renal Physiol. 1999;277:F875-F881.
140. Mucsi I, Skorecki KL, Goldberg HJ: Extracellular signal-regulated kinase and the small GTP-binding protein, Rac, contribute to the effects of transforming growth factor-beta 1 on gene expression. J Biol Chem. 1996;271:16567-16572.
141. Davis BH, Chen A, Beno DWA: Raf and Mitogen-activated protein kinase regulate stellate cell collagen gene expression. J Biol Chem. 1996;271:11039-11042.
142. Svegliati-Baroni G, Ridolfi F, Di Sario A, Casini A, Marucci L, Gaggiotti G, Orlandoni P, Macarri G, Perego L, Benedetti A, Folli F: Insulin and insulin-like growth factor-1 stimulate proliferation and type I collagen accumulation by human hepatic stellate cells: differential effects on signal transduction pathways. Hepatology. 1999;29:1743-1751.
143. Hayashida T, Poncelet AC, Hubchak SC, Schnaper HW: TGF-beta1 activates MAP kinase in human mesangial cells: a possible role in collagen expression. Kidney Int. 1999;56:1710-1720.
144. Tharaux P-L, Chatziantoniou C, Fakhouri F, Dussaule J-C: Angiotensin II activates collagen I gene through a mechanism involving the MAP/ER kinase pathway. Hypertension. 2000;36:330-336.
145. Border WA, Noble NA: Interactions of transforming growth factor-beta and angiotensin II in renal fibrosis. Hypertension. 1998;31:181-188.
146. Hocevar BA Brown TL, Howe PH: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J. 1999;18:1345-1356.
147. Beier F, LuValle P: Serum induction of the collagen X promoter requires the Raf/MEK/ERK and p38 pathways. Biochem Biophys Res Commun. 1999;262:50-54.
148. Cutroneo KR, Phan SH: TGF-beta1-induced Smad 3 binding to the Smad 7 gene: Knockout of Smad 7 gene transcription by sense phosphorothioate oligos, autoregulation, and effect on TGF-beta1 secretion: Bleomycin acts through TGF-beta1. J Cell Biochem. 2003;89:474-483.
149. Lagente V, Advenier C: Tachykinins and airway function. Pulm Pharmacol Ther. 1998;11:331-340.
150. Groneberg DA, Springer J, Fischer A Vasoactive intestinal polypeptide as mediator of asthma. Pulm Pharmacol Ther. 2001;14:391-401.
151. Barnes PJ: Histamine and serotonin. Pulm Pharmacol Ther. 2001;14:329-339.
152. Eynott PR, Groneberg DA, Caramori G, Adcock IM, Donnelly LE, Kharitonov S, Barnes PJ, Chung KF: Role of nitric oxide in allergic inflammation and bronchial hyperresponsiveness. Eur J Pharmacol. 2002;452:123-133.
153. Eynott PR, Paavolainen N, Groneberg DA, Noble A, Salmon M, Nath P, Leung SY, Chung KF: Role of nitric oxide in chronic allergen-induced airway cell proliferation and inflammation. J Pharmacol Exp Ther. 2003;304:22-29.
154. Nicosia S, Capra V, Rovati GE: Leukotrienes as mediators of asthma. Pulm Pharmacol Ther. 2001;14:3-19.
155. Springer J, Geppetti P, Fischer A, Groneberg DA: Calcitonin gene-related peptide as inflammatory mediator. Pulm Pharmacol Ther. 2003;16:121-130.
156. Holgate ST: Epithelial damage and response. Clin Exp Allergy. 2000;30(Suppl 1):37-41.
157. Hirst SJ: Airway smooth muscle as a target in asthma. Clin Exp Allergy. 2000;30:54-59.
158. Wahl SM: Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. J Clin Immunol. 1992;12:61-74.
159. Holt PG, McMenamin C: Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin Exp Allergy. 1989;19:255-262.
160. Hanada T, Yoshimura A: Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 2002;13:413-421.
161. Schramm C, Herz U, Podlech J, Protschka M, Finotto S, Reddehase MJ, Kohler H, Galle PR, Lohse AW, Blessing M: TGF-beta regulates airway responses via T cells. J Immunol. 2003;170:1313-1319.
162. Duvernelle C, Freund V, Frossard N: Transforming growth factor-beta and its role in asthma. Pulm Pharm Ther. 2003;16:181-196.
163. Barbato A, Turato G, Baraldo S, Bazzan E, Calabrese F, Tura M, Zuin R, Beghe B, Maestrelli P, Fabbri LM, Saetta M: Airway Inflammation in childhood asthma. Am J Respir Crit Care Med. 2003;168:798-803.
164. Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, Howarth PH: Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med. 1997;156:642-647.
165. Pulleyn LJ, Newton R, Adcock IM, Barnes PJ: TGFbeta1 allele association with asthma severity. Hum Genet. 2001;109:623-627.
166. Singer AJ, Clark RA: Cutaneous wound healing. N Engl J Med. 1999;341:738-746.
167. Hoshino M, Nakamura Y, Sim JJ, Yamashiro Y, Uchida K, Hosaka K, Isogai S: Inhaled corticosteroid reduced lamina reticularis of the basement membrane by modulation of insulin-like growth factor (IGF)-I expression in bronchial asthma. Clin Exp Allergy. 1998;28:568-577.
168. Puddicombe SM, Polosa R, Richter A, Krishna MT, Howarth PH, Holgate ST, Davies DE: Involvement of the epidermal growth factor receptor in epithelial repair in asthma. FASEB J. 2000;14:1362-1374.
169. Evans MJ, Van Winkle LS, Fanucchi MV, Plopper CG: The attenuated fibroblast sheath of the respiratory tract epithelial-mesenchymal trophic unit. Am J Respir Cell Mol Biol. 1999;21:655-657.
170. Yamashita H, Ten Dijke P, Heldin C-H, Miyazono K: Bone morphogenetic protein receptors. Bone. 1996;19:569-574.
171. Derynck R, Feng XH: TGF-beta receptor signaling. Biochim Biophys Acta. 1997;1333:F105-F150.
172. Miyazono K: Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteins. Bone. 1999;25:91-93.
173. Weaver M, Yingling JM, Dunn NR, Bellusci S, Hogan BL: BMP signaling regulates proximal-distal differentiation of endoderm in mouse lung development. Development. 1999;126:4005-4015.
174. Lu MM, Yang H, Zhang L, Shu W, Blair DG, Morrisey EE: The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Dev Dyn. 2001;222:667-680.
175. Shi W, Zhao J, Anderson KD, Warburton D: Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis. Am J Physiol Lung Cell Mol Physiol. 2001;280:L1030-L1039.
176. Rosendahl A, Pardali E, Speletas M, Ten Dijke P, Heldin CH, Sideras P: Activation of bone morphogenetic protein/Smad signaling in bronchial epithelial cells during airway inflammation. Am J Respir Cell Mol Biol. 2002;27:160-169.
177. Rosendahl A, Checchin D, Fehniger TE, ten Dijke P, Heldin CH, Sideras P: Activation of the TGF-beta/ activin-Smad2 pathway during allergic airway inflammation. Am J Respir Cell Mol Biol. 2001;25:60-68.
178. Cho SH, Yao Z, Wang SW, Alban RF, Barbers RG, French SW, Oh CK: Regulation of activin A expression in mast cells and asthma: its effect on the proliferation of human airway smooth muscle cells. J Immunol. 2003;170:4045-4052.
179. Atkinson C, Stewart S, Upton PD, Machado R, Thomson JR, Trembath RC, Morrell NW: Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor. Circulation. 2002;105:1672-1678.
180. Du L, Sullivan CC, Chu D, Cho AJ, Kido M, Wolf PL, Yuan JX, Deutsch R, Jamieson SW, Thistlethwaite PA: Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med. 2003;348:500-509.
181. De Caestecker M, Meyrick B: Bone morphogenetic proteins, genetics and the pathophysiology of primary pulmonary hypertension. Respir Res. 2001;2:193-197.
182. Matsuse T, Ikegami A, Ohga E, Hosoi T, Oka T, Kida K, Fukayama M, Inoue S, Nagase T, Ouchi Y, Fukuchi Y: Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol. 1996;148:707-713.
183. Brigstock DR: The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. Endocr Rev. 1999;20:189-206.
184. Moussad EE, Brigstock DR: Connective tissue growth factor: what's in a name? Mol Genet Metab. 2000;71:276-292.
185. Bradham D, Igarashi A, Potter R, Grotendorst G: Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1991;114:1285-1294.
186. Igarashi A, Okochi H, Bradham D, Grotendorst G: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell. 1993;4:637-645.
187. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst G: Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol. 1996;107:404-411.
188. Allen JT, Knight RA, Bloor CA, Spiteri MA: Enhanced insulin-like growth factor binding protein-related protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Cell Mol Biol. 1999;21:693-700.
189. Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M, Takehara K: Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol. 2000;27:149-154.
190. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T, Takehara K Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol. 1999;181:153-159.
191. Abreu JG, Ketpura NI, Reversade B, De Robertis EM: Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta. Nat Cell Biol. 2002;4:599-604.
192. Bonniaud P, Margetts PJ, Kolb M, Haberberger T, Kelly M, Robertson J, Gauldie J: Adenoviral gene transfer of connective tissue growth factor in the lung induces transient fibrosis. Am J Respir Crit Care Med. 2003;168:770-778.
193. Branton MH, Kopp JB: TGF-beta and fibrosis. Microbes Infect. 1999;1:1349-1365.
194. Kerzel S, Path G, Nockher WA, Quarcoo D, Raap U, Groneberg DA, Dinh QT, Fischer A, Braun A, Renz H: Pan-neurotrophin receptor p75 contributes to neuronal hyperreactivity and airway inflammation in a murine model of experimental asthma. Am J Respir Cell Mol Biol. 2003;28:170-178.
195. Rubio-Aliaga I, Frey I, Boll M, Groneberg DA, Eichinger HM, Balling R, Daniel H: Targeted disruption of the peptide transporter Pept2 gene in mice defines its physiological role in the kidney. Mol Cell Biol. 2003;23:3247-3252.
196. Groneberg DA, Welker P, Fischer TC, Dinh QT, Grutzkau A, Peiser C, Wahn U, Henz BM, Fischer A: Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J Allergy Clin Immunol. 2003;111:1099-1105.
197. Groneberg DA, Witt C, Wagner U, Chung KF, Fischer A: Fundamentals of pulmonary drug delivery. Respir Med. 2003;97:382-387.